WDFY1 and schizophrenia: As we have seen increased WDFY1 protein levels in the hippocampus and striatum of He–/– mice and in the hippocampus and dorsolateral prefrontal cortex in schizophrenic post-mortem samples, we then hypothesized that pharmacological models of schizophrenia could mimic such molecular changes.